ArticleNeuro-oncology2018

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Signe R Michaelsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.